• Citer

HER2+ circulating tumor cells (CTCs): a more sensitive and specific marker for CTCs positivity than total CTCs count in early breast cancer.

par Ignatiadis, Michail ;Durbecq, Virginie ;Markowicz, Samuel;Chaboteaux, Carole ;Rouas, Ghizlane;Bouzeghrane, M;Bopp, Benjamin ;Liebens, Fabienne ;Georgoulias, Vassilis;Mavroudis, Dimitris;Piccart-Gebhart, Martine ;Sotiriou, Christos
Référence San Antonio Breast Cancer Symposium - SABCS 2008(Dec 10-14, 2008: San Antonio, Tx, USA), Cancer Research, Vol. 69, Issue 2, Supplement 1
Publication Publié, 2009-01

Abstract de conférence

• Détails
• Contenu

Titre:	HER2+ circulating tumor cells (CTCs): a more sensitive and specific marker for CTCs positivity than total CTCs count in early breast cancer.
Auteur:	Ignatiadis, Michail; Durbecq, Virginie; Markowicz, Samuel; Chaboteaux, Carole; Rouas, Ghizlane; Bouzeghrane, M; Bopp, Benjamin; Liebens, Fabienne; Georgoulias, Vassilis; Mavroudis, Dimitris; Piccart-Gebhart, Martine; Sotiriou, Christos
Informations sur la publication:	San Antonio Breast Cancer Symposium - SABCS 2008(Dec 10-14, 2008: San Antonio, Tx, USA), Cancer Research, Vol. 69, Issue 2, Supplement 1
Statut de publication:	Publié, 2009-01
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
Langue:	Anglais